Stock Track | Phibro Animal Health Soars 5% After Hours on Q2 Earnings Beat, Raised Revenue Outlook
Shares of Phibro Animal Health Corporation (PAHC) surged over 5% in extended trading on Wednesday, following the company's impressive fiscal second-quarter results and an upbeat full-year revenue forecast.
For the quarter ended December 31, 2024, Phibro reported adjusted earnings per share of $0.54, comfortably beating analysts' expectations of $0.42. The animal health and mineral nutrition company's revenue grew nearly 24% year-over-year to $309.3 million, also exceeding consensus estimates of $303.84 million.
Notably, Phibro raised its fiscal 2025 revenue guidance to a range of $1.25 billion to $1.30 billion, compared to analysts' average projection of $1.32 billion. The company cited strong demand across its animal health and nutrition businesses for the upbeat outlook.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
No relevant data is available